Tagged with CTI

Sweden Bactiguard is a Swedish medtech company with a global presence, offering prevention solutions for nosocomial infections, reducing the use of antibiotics and the spread of multi-resistant bacteria. Its CEO, Christian Kinch, explains how Bactiguard’s solution works to save lives and reduce healthcare costs. He also shares the company’s international journey…

Thailand Thailand has experienced a steady decline in infectious disease rates in the last generation thanks to the country’s commitment to life sciences research. The executive vice president of the National Science and Technology Development Agency elaborates on Thailand’s research on infectious diseases and how collaboration fuels further progress.    We…

Puerto Rico Gustavo A. Hermida is the president of CIC Construction Group, one of the Puerto Rico’s largest general contractors. Being involved in nearly all larger construction projects in the pharmaceutical, biotechnology and medical device industry, Hermida highlights the importance of business continuity plans and the company’s expansion to the US mainland…

Sweden Swedish biotech BioArctic, in collaboration with Japanese firm Eisai, has seen positive Phase IIb results for its BAN2401 antibody – potentially the first disease-modifying treatment for Alzheimer’s Disease and the next global blockbuster.   The results from the Phase IIb study strengthen BioArctic’s belief that BAN2401’s unique binding profile is…

Thailand Dr Kumthorn Malathum, president of the Infectious Disease Association of Thailand, shares his insight on the issue of infectious disease in the country and the need to develop collaboration in order to tackle these infections.   Due to the country’s climate and people’s way of life, infectious diseases are a…

France André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to the current therapies on the market which uses a patient’s own re-engineered T-cells. Choulika goes on to share how the company is positioning itself for its anticipated commercialization…

Algeria Nadia Oka-Bousbia of bioMérieux Algeria discusses the affiliate’s important role within Algeria’s fight against infectious diseases and the training of health managers, difficulties surrounding import restrictions, and the company’s constantly-evolving strategy for the future.   These are exciting times for bioMérieux locally. We understand that earlier this year, your global…

China Simon, you established Glory Medical back in 1998. What was the main rationale behind this significant decision? “We already have operations in Sri Lanka and Pakistan, and are exploring projects in Indonesia and Bangladesh, as well as in Latin America and the Middle East. Some of these places really need…

Canada Warren Bravo, co-founder and CEO of Green Relief, speaks about the company’s unique growing technique – aquaponics – which allows it to produce ‘better than organic’ medical cannabis. He gives an insight into the organization’s expansion plans, both within and beyond Canadian borders, and a potential IPO in 2018. After…

Ecuador Angel Guevara, molecular biologist and professor at the Central University of Ecuador (UCE), discusses Ecuador’s potential as a clinical trial destination, a diverse tropical country with high prevalence of infectious disease and educated healthcare professionals. He explains the differences between public and private healthcare services, notably from the point of…

Switzerland Kurt Reichen, VP Technical Operations at PaxVax, an American-headquartered fully integrated specialty vaccine company focused on infectious diseases, discusses the establishment of the company’s only site outside of the US in Bern, Switzerland, following the 2014 acquisition of a former Crucell manufacturing site from J&J. The establishment of your Swiss…

Canada Greig Estabrooks, general manager of Valneva, talks partnership opportunities for the French-Austrian pure-play vaccine company in Canada, its exciting pipeline, and how he encourages his global R&D colleagues to consider conducting clinical trials for their pipeline products in Canada in order to leverage the country’s great infrastructure and significant human…